Mesothelioma Resource

Safyral Class Action News – 2/16/2012: Safyral side effects are being investigated by law firms that focus on pharmaceutical and medical device litigation. If you were prescribed Safyral and later suffered serious negative side effects please contact us today so that we can arrange a free legal consultation about potentially recovering money damages for you injuries.

Safyral Class Action : In the acute care setting, the forms of rehabilitation are ini­tially more passive; patients’ activities may be limited by the ma­chines, tubes, and beds they are connected to. Simple therapies start at the bedside: maintaining range of motion, preventing con­tractures (painful shortening of the muscles caused by immobil­ity), and providing stimulation. Regaining one’s life begins nowin the rehabilitation hospital. Each day, every day, patients get dressed, from shoes and socks to shirts and pants, to prepare for the day’s work-even such seem­ingly limited jobs as performing range-of-motion exercises. By beginning the rehabilitation process early on, patients immedi­ately regain some control over their lives—which decreases their anxiety and builds hope for the future.

The old myth that stroke victims do not survive long enough to warrant rehabilitation is dated, outmoded, and completely er­roneous. Research shows that 50 percent of all stroke patients live for at least seven and a half more years—and many even longer. Even more telling are the findings that those who had rehabilita­tion after their strokes had better long-term quality of life. Another rehabilitation success story: stroke patients who have had rehabilitation in a rehabilitation hospital as opposed to a nursing home have progressed from a low level of function­ing to a higher one in a shorter amount of time. Why bring this to your attention? A major study in the Journal of the American Medical Association confirmed that if you have a managed care in­surance plan, you are more likely to go to a nursing home after a stroke. And, more importantly, if you go to a nursing home, you are less likely to do as well—and three times less likely to return to your home.

A stroke survivor’s rehabilitation is a fluid situation with constant change. Needs must be evaluated continuously, and rehabilita­tion goals must reflect any change. With other conditions, taking a comprehensive history and performing an extensive physical examination might be enough. But in stroke rehabilitation, there can be several different physicians, as well as therapists, psychol­ogists, and staff members, who need to analyze the patient ac­cording to their expertise. A sound rehabilitation plan has to take all this input into account, plus the patient’s individual needs, potential, and goals.

Safyral Class Action News: More information about your search

Safyral Class Action : A common result of stroke is hemiplegia, or paralysis, on one side of the body. This paralysis means a patient may have trouble with movement in the affected area, or that he cannot make any voluntary movements. A paralyzed stroke survivor might feel as if his body were limp or flaccid. And although he cannot move, he still might experience pain. Temporary or minor paralysis will usually not affect rehabil­itation outcome. Significant paralysis, however, can be associated with functional deficits, most likely because it is combined with other problems. One particular study found that those stroke pa­tients with severe motor dysfunction also had problems with de­cision making, communication, and sensory perceptions—all of which can adversely affect rehabilitation.

Spasticity is, literally, an imbalance of muscle tension, caused by a malfunctioning set of passageways in the brain that is triggered by the stroke. This malfunction causes a resistance to passive motion. For example, if a person with spasticity tries to straighten his elbow to put on his shirt, the muscles on one side of the elbow resist the movement, keeping the arm from moving in the desired direction. The result is a prolonged contraction, a tightness that can not only be extremely frustrating, but painful as well. Spasticity can make an arm or leg appear frozen.

During your recovery from a stroke, the spasticity in your hand and arm muscles may prevent you from taking full advan­tage of your returning strength. By weakening the overactive, spastic muscles, the returning muscles can have more range of motion; they can be furthered strengthened during the rehabilita­tion process as you now take full advantage of all your exercises. Or perhaps your stroke left you with a spastic, tightly clenched fist that is painful, difficult to clean, or place through the armhole of a shirt while dressing. Botox® can relax these muscles and de­crease the pain. And, most important, although Botox® may not necessarily increase your ability to use your arm in this particular situation, it will absolutely increase the quality of your life.

Safyral Class Action News: Additional Information and Resources

Safyral Class Action : Before any physical therapy begins, a patient must be evaluated. He might be asked to try to stand in the parallel bars. Often, someone who is paralyzed can still support his weight on his weakened leg; he must learn the proper sequence for walking and how to advance his paralyzed leg. Treatment includes: range-of-motion exercises, strengthen­ing exercises, parallel bar exercises, balance activities, and learn­ing how to use a wheeled walker and quad (four-legged) canes. Family members are taught: proper techniques for car transfers, and getting from one place to the next when the patient has a pass to go home—and within the family’s community.

The lack of movement or prolonged sitting in a wheel­chair can lead to edema—swelling in the legs that can be more than uncomfortable. It can lead to phlebitis, or dangerous blood clots, which can break off and travel to the lungs. Treatment includes: medication to reduce swelling and flu­id retention, and to prevent the formation of blood clots; and the use of elastic stockings and gloves. Elevation of legs and arms also decreases swelling.

Often ankle control becomes a problem in lower-extremity weak­ness. A stroke survivor might have trouble walking because she can’t lift her foot; the foot drags in a condition called “foot drop.” She might find that her foot turns inward in a condition called “inversion” despite her desire to move it straight. She might not even be able to feel how her ankle and foot are positioned.

Physical therapy is only one part of the plan. When a reha­bilitation team designs a therapy program, they know that occu­pational, cognitive, and speech therapies all must be included. A patient with arm, shoulder, or hand problems may have to learn how to perform his activities of daily living with one hand. He may have to learn how to get dressed with one hand. He may have to learn new ways to comb his hair. He may have to relearn the steps involved in making lunch or dinner. This same patient might need to improve his eye-hand coordination. He might need to compensate for impaired sensory perception. The skills in­volved in all these different functions and tasks are the work of the other members of the rehabilitation team.

Safyral Class Action News: News and Information from related Sources

Safyral Class Action : What it is: In subluxation, a stroke interferes with the prop­er alignment of the shoulder joints as well as shoulder muscle strength. The shoulder literally becomes separated from its joint because the paralyzed muscles can no longer hold it in place. Treatment includes: range-of-motion exercises for the shoulder. Patients are taught not to catch their hands or arms in wheelchair spokes. They are trained to be careful, making sure that their arms don’t fall off their lap trays, that they don’t sleep on their arms, that their arms always are supported while sitting up. Their wheelchair may be fitted with an arm support or lap tray to keep the shoulder in place. If the shoulder and arm are paralyzed, a sling may be recommended for use at certain times (although, in general, we limit the use of slings because they can decrease range of motion).

Complex regional pain syndrome (CRPS) used to be called reflex sympathetic dystrophy or shoulder/hand syndrome. It can occur in a paralyzed arm after a stroke. Movement becomes very painful, especially in the shoulder, wrist, and hand. The arm and hand can become swollen and exceedingly sensitive to touch. CRPS is seen following nerve and soft tissue injuries and arm injuries. The onset of CRPS usually occurs within three months after a stroke.

Treatment includes: sympathetic nerve blocks; steroid in­jections; range-of-motion exercises, including slow arm swings, arm lifts, and neck twists; and limb support through splints and braces. Medications, such as amitriptyline and Lyrica®, can be very helpful in reducing the pain. Taping of the shoulder joint with Kinesiotape® is proving to be useful in selected patients. Family members are taught: to watch out for the signs of CRPS, including pain and swelling, and to keep the paralyzed arm elevated. To prevent CRPS, family members should try to keep their loved one on a regular exercise regime and make sure that splints and braces are fastened correctly.

A stroke survivor might need a hand or wrist splint to keep the hand or wrist in a proper position, decrease any swell­ing or joint complications, and prevent clenched fists or other spastic contractures. These splints usually are made of hard plas- tic-like materials that can be easily shaped to the patient’s hands, wrists, or fingers, A resting hand splint extends from the forearm to the fingertips. A cock-up splint is similar to the resting hand version, but it allows more freedom of movement for the hand. Wrist splints are designed to help position the forearm, the wrist, and the palm and fingers. The finger-spreader splint is specifi­cally created to prevent clenched fists. It looks like a wedge made of plastic; the fingers poke through troughs similar to a glove.

Very simply, memory is defined as the function in the brain that registers, consolidates, and, later, retrieves information. That information is selective and unique to each person. It is based on what he sees, what he reads, what he thinks. If the memory process is interrupted anywhere along this register-retrieve con­tinuum, there may be a temporary or permanent loss.

Our use of the term or terms Safyral Class Action is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Safyral Class Action News visit our site often.

Safyral Class Action

Safyral Lawyer News – 2/16/2012: If you were prescribed Safyral and have suffered negative side effects, please contact us today so that we can put you in touch with an attorney to advise you of your legal rights.

Safyral Lawyer : Another way to get estrogen to the vagina and bladder is to use an estrogen ring (Estring). The estrogen ring is a small silicone ring that is inserted in the vagina. The ring contains a very small amount of estrogen that is released slowly over ninety days. The ring can be left in place continuously and does not need to be removed for any activity, including exercise, bathing, or inter”course. Along the same lines, Vagifem is a small estrogen tablet that is easily inserted into the vagina with an applicator twice a week. The tablet sticks to tire vaginal wall and releases small amounts of estrogen over a few days. With either of diese methods, the dose of estrogen is low and virtually none is absorbed into the bloodstream. As a result, virtually no estrogen makes its way to the heart, bones, uterus, or other cells of the body, and no proges”terone is needed to protect the uterine lining. The downside is that because the dose of estrogen is low, it may take longer to work. However, once the cells are healthy again, these methods are more convenient to use than the cream.

There are other medications—imipramine and doxepin are examples-—-that not only reduce bladder spasms but also help keep the muscles in the urethra closed. They were initially prescribed in high doses to combat depression, but by chance researchers discovered that low doses of the same medication often helped with urgency incontinence. There is no connection between depression and urgency incontinence; the medications simply seem to help both. These medications can be used alone or in combination, depending on individual circumstances. All require a prescription and medical supervision, so you should discuss their use with your doctor. Newer medications are being developed all the time, and it is a good idea to ask your doctor about what might be newly available to help you.

In rare cases, these decongestants may also cause increased blood pressure or rapid heartbeat. Avoid them if you have high blood pressure. Other similar and frequently used drugs for stress incontinence are phenylpropanolamine (Omade, Dimetapp), which are prescription drugs and must be supervised by your doctor. If you are postmenopausal, using estrogen in combination with these medications may help improve their effectiveness. Mixed incontinence is a combination of urgency incontinence and stress incontinence. The bladder wall has spasms, and the sphincter muscles are weak and cannot prevent leaking. Thus, this type of incontinence requires a dual solution in the form of a combination of the types of medications described above. A drug that relaxes the bladder wall muscle is used in conjunction with a drug that keeps the bladder sphincter closed. Estrogen is also usually added in postmenopausal women to keep the tissues more elastic and healthier.

When medication is taken in small doses, the side effects are generally negligible. Some medications may cause dry mouth, dry skin, nausea, or constipation. In rare cases, patients may experience blurred vision, slight confusion, or dizziness. Side effects may differ from one medication to another; therefore, changing medications may eliminate any problems. The goal, then, is to work with your doctor to get the proper dose of the right medication to help you, while avoiding particular medications or dosages that result in vexing side effects. It is very important to let your doctor know about any other medications you may be taking for other medical problems. Drugs can interact with each other, changing the effectiveness of one or both. Additionally, the combination could lead to more severe side effects. You should also tell your doctor about any other medical problems you have. For example, some of the drugs prescribed for incontinence may worsen glaucoma.

Some women do not respond to medicines, devices, or exercises but are not interested in surgery. For these women, patches are available that can be placed directiy over the urethra, blocking the flow of urine and preventing incontinence. One such patch, called FemAssist (produced by Insight Medical Corp., Boston, Mass.), is a soft plastic suction cup that fits over the urethra and prevents leakage. It can be used for a few hours, just when it is needed. For women who need protection only when they are exercising or hiking, this patch may be sufficient. For women who don’t mind wearing pads in die house but want to avoid them while they are outside, die patch may be the answer.

Safyral Lawyer News: Additional Information and Resources

Safyral Lawyer: One of the goals of surgery for die treatment of incontinence is restoring the bladder and urethra to their normal position. Most women who have given birth vaginally have some degree of loosening, stretching, and even tearing of the supporting ligaments of the vagina, bladder, and rectum (see Chapter 4). This weakening of the supporting ligaments usually begins unnoticed and without any symptoms and remains that way for the majority of women for their entire lives. But for some women, the changes that occur as a result of the lengthening and stretching cause significant incontinence that interferes witii their daily lives.

Since the abdominal incision needs time to heal, some activity is restricted. For die first week, you can get up for meals, go to the bathroom, and take short walks. You will be fatigued, and simple activities will make you tired. After the first week you will feel stronger, be able to take longer walks, and need less rest. After about two weeks, some women begin working again from home. A few who can’t avoid it go to work for a few hours a day. It takes about six weeks for most of the healing to take place. Most doctors recommend that you not do any exercise or lift anything heavier than 15 pounds for three months. This allows the formation of strong scar tissue that will hold the bladder in die proper position. After surgery, you probably should never lift anything heavier than 25 pounds. You don’t want die force of lifting to stretch and weaken the repair work.

The surgery starts with a small incision made in the vagina, just below die urethra. Small tunnels (about ^lfz inch wide) are then made in die connective tissue on either side of the urethra and into the space just behind the pubic bone. The sling is placed under the urethra at tiiis point, and the ends of the hammock are brought up to the connective tissue on top of the abdominal muscles and fastened. There are a number of materials that can be used to make the sling. Some doctors prefer to use a synthetic, nylon like material, while others choose fascia, die strong tissue that surrounds muscle, either removed from the patient or sterilized, irradiated fascia from a cadaver donor.

An anterior, or cystocele, repair was one of the first operations developed to support the bladder and urethra to prevent incontinence. The operation supports the bladder from underneath but does not correct the loss of support experienced with the extra pressure of a cough or exercise. The anterior repair is performed through a vaginal incision just under the bladder and uses stitches to pull the strong vaginal tissue together for support. This restores die bladder and uretiira closer to their original positions. Unfortunately, this operation does not work very well for incontinence, widi only 37 percent of women having long-term (five-year) cures. Many doctors still use this operation for incontinence even though it is no longer state of the art. An anterior repair is a very good procedure for putting a dropped bladder back into place to relieve bulging of the bladder (see cystocele, Chapter 8). It is also helpful for women who are unable to empty their bladder because of the urine that collects in the bulging portion. But if leakage is a problem, we perform a bladder suspension operation, sling procedure, or TVT in order to successfully treat stress incontinence.

Safyral Lawyer News: News and Information from related Sources

Safyral Lawyer : As the name suggests, the operation is performed through an incision in the vagina, rather than the abdomen. A small vaginal incision is made around die urethra, exposing its supporting dssues. Through tins vaginal incision, stitches are placed in the supporting tissue (the fascia) next to the bladder and urethra. The ends of these long sutures are then threaded through the end of a long, narrow instrument and pulled back through a small (i-inch) incision over the pubic bone. The sutures are then tied to the layer of strong fascia on top of die abdominal muscles.

Whereas the Burch procedure attaches the urethra to an immovable pubic ligament, most vaginal suspension operations attach the urethra to connective tissue and muscles that move when you move and therefore can stretch or break the sutures. Stretching can loosen the repair work and make the surgery less effective over time. For that reason this operation is less effective over the long run, with cure rates in the 45 percent range after five years. Although some doctors still perform this procedure, we have eliminated it in our own practice because it is not effective over time.

Most women spend one night in the hospital after a vaginal bladder suspension. They are able to eat on die same day as surgery. Since there is only minimal discomfort, they can be up walking the same day. Walking is the best exercise during the recovery period; it is not too strenuous but gets most of the muscles in the body going again and keeps the circulation moving. However, the sutures still need to heal, and the bladder still needs to form strong scar tissue to hold it in the proper position. Therefore, exercise other than walking and lifting more than 15 pounds still needs to be restricted for three months. In the event that the diagnosis is mixed—both stress and urgency—-incontinence, there are several issues to understand before agreeing to surgery. Surgery can put the urethra and bladder back where they belong, but this may cure only the stress component of the incontinence. The bladder’s errant spasms may continue to cause urge incontinence and wetness. To completely address mixed incontinence, surgery can be combined with any of the other nonsurgical treatments for urge incontinence.

Now there is a new and effective treatment for one type of incontinence, ISD (see Chapter i), which has changed the lives of many women who have leaked for years. ISD may be a result of surgery for incontinence that caused excessive scarring or damaged nerves near the urethra. As a result, the urethra does not close properly and leaking occurs. Collagen is a natural substance that adds strength and elasticity to most of the tissues of the body. When taken from cattle and purified for medical use, it has the consistency of thick glue and can be administered by injection. You are probably familiar with the use of collagen by injection since it is commonly used by dermatologists to soften wrinkles in the skin.

The use of collagen for treating incontinence is a simple procedure performed in a doctor’s office or hospital, with either local or general anesthesia. A small telescope is placed into the urethra and a small needle is passed through the telescope. The surgeon guides the needle to the portion of the urethra very close to the opening of the bladder. When the collagen is injected into this tissue, it solidifies quickly and causes the urethral lining to bulge inward, making the urethra dose off at this point. The partial blockage of the urethra by the bulging collagen helps the urethra stay closed during a cough or upon exercise.

Safyral Lawyer News: Information and News

Safyral Lawyer: For women with a severe, otherwise noncorrectable incontinence problem, a surgical procedure can implant an inflatable ring around the urethra. The ring is connected to a small inflating bulb that is placed under the skin to control the opening and closing of the urethral ring. Pressing on one part of the bulb allows the ring to deflate and urine to be passed easily. Pressing on another part of the bulb inflates the ring and keeps the patient dry. This is a difficult procedure to perform but may be indicated for women with an intractable incontinence problem. Interstim is a surgical method to control symptoms of a hyperactive bladder. Interstim works by electrically stimulating the spinal cord nerves and causing them to relax. Although this is a surgically implanted device, it does not involve surgery on the pelvic organs or muscles. However, since it uses a permanently implanted device, it should be considered only for women who have tried and failed to correct their bladder spasms with other methods.

Millions of women are significantiy happier because ofhaving had bladder surgery of one type or anotiier. There is an excellent American study that followed women for five years after three different operations performed for stress incontinence. The women who had abdominal bladder suspensions had the best five-year success rate; about 80 percent were still dry. About 45 percent of the women who had vaginal needle bladder suspensions were still dry after five years, and the women with anterior bladder repairs had success rates in the 35 percent range. Sling surgery has a high cure rate, around 90 percent, for women who have previously had a bladder operation that has failed. The procedure has a short recovery period. However, urgency may sometimes follow the operation. TVT is very effective, with success rates around 85 percent after five years.

Your decision about whether to have surgery at all and, if so, which surgery to have should depend on a number of factors and should be made in collaboration with your surgeon. First, while there may be a number of surgical options for a particular type of incontinence, one operation may be more likely to succeed tiian others, given your specific test results and symptoms. The severity of the incontinence may also affect your decision. If you have a more bothersome situation, you may be willing to undergo a more involved procedure and a longer recovery to fix the problem.

Other factors that should be considered are your age and general physical condition. The lifestyle you lead is important. If you are not very active and can avoid activities that put stress on your bladder, a less extensive procedure may be enough to correct a problem to your satisfaction. Very active women will often require a more extensive repair to withstand the additional stresses their day-to-day activities put on the bladder. While most operations have good long-term success rates, some women may require another operation during their lifetime to correct recurrent incontinence. We know that some of the factors that contribute to incontinence are not yet treatable, such as persistent nerve injury from childbirth or weak supporting tissue due to your own body’s innate poor-quality collagen. In some cases, activity may cause sutures to tear out or scar tissue to weaken over time, and the incontinence problem returns. For these reasons, some women may require another operation later in life.

Our use of the term or terms Safyral Lawyer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Safyral Lawyer News visit our site often.

Safyral Lawyer

Safyral Litigation News- 2/16/2012: Please contact us today if you took Safyral and suffered unusual side effects or other injuries.

Safyral Litigation : High blood pressure can be regulated. You are in control. But some of the risk factors of stroke are beyond your powers. They are simply a fact of life. Aging is one of them. As you age, your arteries become more fragile. They are less elastic and flexible. They become brittle. This hardening of the arteries is called atherosclerosis. The more the buildup of athero­sclerosis, the more likely these arteries are to clog or close off. If this occurs in the brain, it will result in stroke.

At first glance, diabetes seemingly has nothing to do with stroke. After all, it is a disease that impairs the body’s ability to control the level of sugar. But below the surface of that definition is a very strong—-and dangerous—connection. Diabetes can affect circulation. And poor circulation can affect the blood vessels, es­pecially the small capillaries in the eyes. Here, because of weak­ened, impaired blood vessels, diabetes can cause hemorrhages and blindness. Likewise, similar hemorrhages within the brain.

We all talk about it. We check labels for it. We get our blood checked for it. But many of us are not quite sure what cholesterol is—or its connection to disease. Basically, cholesterol is a waxy material that the body manu­factures, and, believe it or not, it’s natural and necessary for many of our functions. But today, there can be too much of a good thing. Not only does the body manufacture cholesterol, but cholesterol also is found in many of the foods we eat, such as steak and eggs. And saturated fats found in such foods as meat, cheese, milk fat, shortening, and even margarine contribute even more to higher blood cholesterol levels than does dietary intake of cholesterol.

Cholesterol is carried in the bloodstream by lipoproteins, a “shopping cart” substance of fat and protein produced by the liver. The lipoprotein that does most of the work is low-density lipoprotein (LDL) cholesterol. All well and good, but once the body has taken what it needs, the LDL is still floating around, all dressed up with nowhere to go. Eventually, this floating LDL cholesterol settles on the artery walls, clogging passageways or causing clots that could break off and travel to the brain. This is why LDL is called “bad cholesterol.” But LDL does not travel alone. There is a “good cholesterol” at work as well: high-density lipoprotein (HDL). HDL carries cholesterol back to the liver for processing and elimination.

Safyral Litigation News: More information about your search

Safyral Litigation : The risk of high cholesterol comes from the amount of LDL in the bloodstream. Cholesterol has received most of its press from its relationship with heart attacks. Indeed, until recently, cholesterol has not been considered a risk for stroke. But new re­search has shown that lowering cholesterol is important in stroke prevention. A recent study of the new “statin” drugs showed that by lowering LDL cholesterol by 23 percent to 42 percent, the risk of stroke was decreased by 29 percent. In short, cholesterol levels, especially LDL cholesterol, must be watched. The current recommendation is keep your choles­terol below 200MG/DL, and if your LDL is more than 100MG/ DL you should be on a statin medication. High-risk patients with multiple risk factors should try to get their LDL down to 70MG/ DL. And if your levels are high, help decrease the numbers by eating a low-fat diet, taking cholesterol-lowering medication, and exercising regularly. You are never too young to know your cho­lesterol level and to start working on a healthy lifestyle.

Usually our hearts beat in a monotonous but reassuring reg­ular rhythm. But, particularly as we age, they may adopt a highly irregular beat called atrial fibrillation. These irregular beats of the atrium are less efficient, and blood clots can form in the heart, poised and ready to head to the brain. A person with atrial fibril­lation is 4 percent to 18 percent more likely to have a stroke. In some cases, blood clots may form on a damaged heart valve. Diseases like rheumatic fever can leave roughened, floppy heart valves that attract small bits of debris and blood clots. At other times, a heart attack may leave a section of the heart muscle weakened—another magnet for those dangerous blood clots that might break off and travel to the brain.

It is a fact—-smoking doubles the risk of having a stroke. That’s right, you are twice as likely to have a disabling stroke if you smoke. Smoking has a major distinction: it is the most pre­ventable of all the risks for stroke. Simple. But, as anyone who has ever smoked knows, quit­ting is easier said than done. Even though studies have found that smokers are one and one-half to three times more at risk for stroke than nonsmokers, even though smoking adversely affects circulation and blood supply, and even though the risk of smok­ing is high with or without taking into account high blood pres­sure, heart disease, and age, many people continue to smoke.

Safyral Litigation News: Additional Information and Resources

Safyral Litigation : Birth control pills have helped shape the way we think, the way we act, and, obviously, the way we conceive. They helped give birth to women’s rights. They influenced an entire generation of young adults. But as the years pass, studies have found that there are some side effects with oral contraceptives. One of these is the risk of stroke, especially in women over the age of thirty who .have a history of hypertension and smok­ing. One study of stroke in young women discovered that certain women who used birth control pills were at an increased risk for stroke compared to women who did not. This risk increased in women who have hypertension. And other studies show there is also a connection between oral contraceptives, heavy cigarette smoking, and stroke. The overall risk is quite small, so you need to weigh it against the fact that pregnancy itself carries a risk. The decision is difficult, but women who are older, hypertensive, and smoke should consult their doctors regarding the risks of taking birth control pills.

Unfortunately, this decline has plateaued recently, which further shows that other risk factors must be treated as well. A lower-fat diet that is also lower in salt, exercise, weight loss, no smoking, even taking one drink of alcohol a day (but don’t forget that heavy drinking increases the risk of stroke!)—all these can help reduce the risk of stroke. And reducing one risk factor can have a favorable outcome on the others. As we have seen, many conditions are related: high cholesterol and hypertension, obesity and diabetes. Treating one of these factors can help treat another.

Because of the configuration of arteries in the brain, the area hit by the ‘‘drought” usually forms a wedge shape. Visualize it as the sprinkler system you use on your lawn. If one sprinkler head malfunctions, the wedge of grass it watered will die. As with all other aspects of stroke, location is everything. Small or large might not be important with infarction. Rather, it is where the infarction took place that decides a person’s fate. Even a small infarction can cause severe disability if it occurs in a vital area. If the brain tissue dies in the interior area of the brain, it can cause paralysis on one-half of the body. If it is in the occipital lobe area, it can affect vision.

It’s called a thrombosis, the most common form of stroke. In fact, 80-85 percent of all strokes are ischemic in nature. Here, the blood flow in the brain, either deep in its interior or in the less deep carotid artery in the neck, is blocked because of a clot that forms in the artery. Atherosclerosis is its greatest influence. Think of it. Either through cholesterol deposits or aging, the in­side walls of the arteries become less flexible; thick deposits of fat form, and passageways become too narrow for blood to flow through smoothly. Instead, the blood forms a clot around these thick deposits as it tries to get past.

Safyral Litigation News: News and Information from related Sources

Safyral Litigation : Ironically, these clots usually begin as a healthy measure. The deposits or rough places on the artery wall are seen by the body as a “call to arms,” a need to stave off infection. The blood, thinking these areas need repair, clots around them. Platelets send out their thin clotting fibers. Red and white blood cells join in the action. Soon, the clotting has a life of its own, acting like a net as it pulls platelets, red blood cells, even bits of floating cholesterol into its web. A scab can form, making the mass of cholesterol and blood even thicker. The result? A clogged-up passageway that life-sustaining blood can’t pass through. The ultimate result? A thrombotic stroke.

This type of stroke, too, is caused by a clot. These embolic strokes are less common than their thrombotic cousin. But these clots, called emboli, are the traveling salespeople of stroke, a mass of tissue, blood, and cholesterol that originates somewhere else in our body, usually in the heart or the neck’s carotid artery, only to end up in the brain. Here, when the clotting action occurs, a piece of clot eventually breaks off. This clot, or embolism, is carried by the bloodstream to the brain, where the arteries are smaller. Soon, the clot gets stuck, literally plugging up the passageway beyond it. Blood simply cannot get past the embolism. A third type of stroke has less to do with infarction’s “drought” than it has to do with flooding.

Only 10 percent of all strokes are hemorrhagic. But hemorrhagic strokes are also the most deadly. There is good news, however: studies have found that if people survive hemorrhagic strokes, they can make the greatest and most dramatic gains over time in rehabilitation. Hemorrhagic strokes usually are helped along by hyperten­sion, which weakens and changes the artery walls in the brain. A weakened wall eventually ruptures, spilling blood into the brain. Sometimes this problem is congenital, a condition that has ex­isted since birth. Unfortunately, high blood pressure can stretch this already vulnerable wall to its limits. In the same way a worn tire can explode one day while you are driving, this wall can ul­timately burst. We call this medical “blowout” a ruptured aneu­rysm—which sends blood all around the surface of the brain.

Our use of the term or terms Safyral Litigation is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Safyral Litigation News visit our site often.

Safyral Litigation

Safyral Side Effect News – 2/6/2012:

You deserve to be compensated if you took Safyral and suffered side effects that the public was not warned about. Contact us today and we will arrange a free consultation with a lawyer experienced in pharmaceutical and medical device ligation that can advise you of your legal rights.

Safyral Side Effect News: More information about your search

Safyral Side Effect News:

Before a prothrombotic state is sought in patients with recurrent pregnancy loss, structural, cytogenetic, and endocrinological abnormalities should be ruled out. If no other cause for the pregnancy loss can be discerned, an antiphospholipid antibody should be sought. It remains controversial whether other causes of a prothrombotic condition should be investigated such as the factor V Leiden muta­tion, the prothrombin gene mutation, or hyperhomocysteinemia.

There are many published reports of strategies used for the prevention of fetal loss in patients with APS. However, only a few present data derived from well- designed and executed clinical trials. To provide the most rigorous possible con­clusions, we have limited this review to treatment recommendations derived from studies in which all patients had a persistently positive antiphospholipid antibody and two or more first-trimester pregnancy losses or one or more second- or third- trimester losses. We excluded studies including patients with secondary APLA, such as those with SLE, to eliminate confounding effects of the underlying dis­ease on the likelihood of successful pregnancy outcome, and we excluded nonran­domized studies with less than 10 patients because of the potential for bias in these small case series.

One recently reported study is relevant to this review, but is not included in the analysis because it did not satisfy the inclusion criteria. The randomized controlled trial published by the Pregnancy Loss Study Group (59) enrolled 16 patients, 9 of whom received heparin and ASA, and 7 of whom received heparin, ASA, and IVIG administered in a dose of 2 g/kg monthly from documentation of pregnancy until 36 weeks gestation. All 16 patients enrolled in this study delivered successfully. However, it was not clear whether the antiphospholipid antibody titer was confirmed on at least two occasions.

Low-molecular-weight heparins are an attractive alternative to standard heparin for many indications because, in animal models, they produce less osteo­porosis than standard heparin, yet they appear to be at least as effective as standard heparin. This suggests that low-molecular-weight heparins would be an excellent choice for anticoagulation during pregnancy. However, until good-quality evidence exists for the effectiveness of the low-molecular- weight heparins in patients with an antiphospholipid antibody and recurrent preg­nancy loss, their routine use cannot be recommended.

In summary, based on currently available literature, it appears that the treat­ment of choice for the prevention of pregnancy loss in women with APS is low- dose heparin and aspirin. Although we cannot confidently exclude the possibility that prednisone plus ASA therapy is as, or more, effective than heparin plus aspirin therapy, prednisone-containing regimens are associated with a higher risk of maternal and obstetric toxicity. In addition, based on our analysis, we conclude that rigorous clinical trials designed to determine the optimal type and duration of treatment to enhance the likelihood of live birth are urgently needed.

Safyral Side Effect News: Additional Information and Resources

Safyral Side Effect : As with all other areas in this field, there remain many unanswered questions. Although one small study suggests that low-dose unfractionated heparin increases the likelihood of successful pregnancy outcome, there are no independent, ran­domized studies to support this conclusion. Low-molecular-weight heparins have replaced unfractionated heparin in many clinical circumstances; whether low- molecular-weight heparin can replace unfractionated heparin in this patient popu­lation has never been tested in a randomized clinical trial. Aspirin therapy is widely accepted in this patient population, yet its efficacy has never been proven in a methodologically rigorous study. Finally, the role of anticoagulants or immu­nosuppressant therapy has never been tested in women who are unable to con- cieve, or those with pregnancy loss at less than 8 weeks gestation.

Furthermore, the response of patients with anti­phospholipid antibody-associated thrombocytopenia to immunomodulatory therapy supports the hypothesis that the thrombocytopenia is due to immune plate­let destruction. No large prospective studies of therapy for antiphospholipid anti­body-associated thrombocytopenia have been reported. However, based on anec­dotal experience, therapy with corticosteroids, intravenous immunoglobulin, immunosuppressive agents, and, ultimately, splenectomy for patients with severe, refractory thrombocytopenia may be effective. Galindo and colleagues re­ported their experience with 11 patients who underwent splenectomy for severe, refractory thrombocytopenia. Nine patients had a good clinical response, as de­fined by platelet counts in excess of 100 X 10⁹/L without pharmacological ther­apy. Many patients with immune platelet destruction will have markedly low platelet counts (30 to 50 X 10⁹) yet be asymptomatic; such patients are best treated with careful monitoring, rather than potentially toxic interventions. If therapy for thrombocytopenia is required, platelet counts can usually be temporarily increased with corticosteroids or intravenous immunoglobulin.

Considerable evidence supports a relation between postmenopausal hormone therapy and cardiovascular disease. Specifically, long-term use of hormone ther­apy is associated with substantial protection against heart disease. This protection, observed largely in observational epidemiological studies, may be due, in part, to self-selection bias. Women who take hormones may not be completely compa­rable to those who do not; women on hormone therapy see a physician regularly and may lead generally healthier lifestyles. However, adjustment for known car­diac risk factors in many of the large studies of homogeneous populations had little impact on their results, implying an equivalent risk status for users and nonusers. To date, however, no randomized trial data in primary prevention have been presented. The effect of progestin added to estrogen therapy has not been adequately assessed, but initial evidence suggests that most of the coronary bene­fit is probably retained. Considerable controversy exists regarding the effect of hormones in women with established coronary disease, although, like the studies of primary prevention, existing data suggest long-term benefits. On the other hand, the only randomized trial in secondary prevention, the HERS study, failed to show the expected benefits of this approach over a 4-year period of observation.

Cardiovascular diseases (CVD) remain the leading cause of death in women. The role of hormone therapy in CVD remains a controversial topic, de­spite clear evidence from randomized clinical trials that hormone use improves the lipid profile, enhances blood flow, and has numerous other beneficial effects on intermediate endpoints. This chapter summarizes the epidemiological investi­gations regarding the association between postmenopausal hormone therapy and cardiovascular disease, including primary and secondary prevention of coronary heart disease, stroke, and pulmonary embolism. For coronary heart disease, sub­stantial evidence on primary prevention has accumulated from numerous observa­tional studies. Less consistent information is available on the relationship between stroke and hormone therapy. Finally, few studies have examined the relation of hormone use to second coronary events or to pulmonary embolism, but the only completed large-scale clinical trial of hormone therapy addresses these issues.

Safyral Side Effect News: News and Information from related Sources

Safyral Side Effect : Overwhelming evidence from epidemiological studies indicates an inverse rela­tion between hormone use and heart disease in healthy women. Several observa­tional study designs have been used to examine this association: hospital and community-based case-control studies; cross-sectional studies; and prospective studies; virtually all report a lower risk of heart disease for women who take hormones than those who do not. In addition, results from all the studies have been combined in several meta-analyses, with summary relative risk esti­mates in all these indicating approximately a 35% lower rate of coronary heart disease (CHD) for hormone users than nonusers. However, many studies suggest that current hormone users enjoy greater protection against heart disease than past users. Thus, combining investigations of current, past, and ever use in a summary estimate is misleading because the results will be directly affected by the proportion of past and current use in the studies included. As expected, summary estimates based on analyses of current use are lower than those derived by combining studies of any hormone use. For all studies of current use.

Of the studies included in the meta-analyses, the Nurses’ Health Study is the largest prospective cohort to investigate hormone use and heart disease. The study was established in 1976 when 121,700 married female registered nurses aged 30 to 55 years completed a mailed questionnaire. Information on coronary risk factors and hormone use was updated with follow-up questionnaires sent every 2 years. Reports of coronary disease are confirmed by medical record review, and data on hormones and other possible risk factors are likely to be reliable since all subjects are registered nurses, with a demonstrated interest in medical research. In the analysis of hormones and heart disease, a total of 70,543 postmenopausal women without prior coronary heart disease were followed for up to 20 years; 945 nonfatal myocardial infarctions and 186 confirmed coronary deaths were documented.

Preliminary data released from the Women’s Health Initiative, an ongoing, large randomized clinical trial of hormone therapy and cardiovascular disease in healthy women, suggested that there may be a slight rise in the risk of heart disease, stroke, and venous thrombosis during the initial 1 to 2 years of hormone use, followed by a decrease in risk with continued use. Unfortunately, there is very little additional evidence available on this issue; most of the observational studies mentioned above primarily consist of long-term hormone users, and very few investigations have specifically examined the short-term effects of hormone therapy on CVD. In the Leisure World Study, a large prospective observa­tional cohort, the relative risk of CHD was 0.73 (95% CI, 0.46-1.16) for recent hormone users of 3 or fewer years duration compared to nonusers; although this estimate of duration was based on a single assessment of hormone use at baseline. In the Nurses’ Health Study, current hormone users of less than 2 years had a relative risk of CHD of 0.53 (95% CI, 0.31-0.93); but, since information is collected biennially, the actual duration of use would be underestimated.

In a small prospective study, Avilaetal found little relation between less than 1 year of current hormone use (RR = 0.9; 95% CI, 0.4-1.9) and MI. In case-control studies, Sidney etal observed no association between current hormone use of less than 1 year and MI (RR = 0.95; 95% CI, 0.37-2.45), and Heckbert also reported that current hormone use of less than 1.8 years was not related to myocardial infarction (RR = 0.91; 95% CI, 0.60-1.38). In the latter study, there was a trend of decreasing risk of MI with increasing duration of hormone use (RR = 0.55; 9% CI, 0.34-0.88 for 8.2 years or more), similar to that reported in the information released by the Women’s Health Initiative. Clearly additional data are necessary.

Safyral Side Effect News: Information and News

Safyral Side Effect : Currently, progestins are prescribed along with estrogen in women with a uterus to reduce or eliminate the excess risk of endometrial cancer due to unopposed estrogen. However, progestin use was quite uncommon during the period that most of the epidemiological studies were conducted. Hence, most of the data are related directly to use of estrogen alone. In studies of intermediate endpoints, randomized clinical trials report significant decreases in LDL and increases in HDL for women assigned to estrogen combined with progestin, but for HDL, the elevation among users of estrogen with medroxyprogesterone acetate (the most commonly used progestin in the U.S.) is significantly less than that for users of estrogen alone. In addition, while estrogen therapy improves blood flow, limited studies suggest that this benefit may be diminished with the addition of progestin. Thus, progestin might be hypothesized to detract from the overall bene­ficial effects of estrogen on heart disease.

Nonetheless, in the few observational epidemiological studies of primary prevention which separately examine combined hormone therapy, virtually all strongly suggest a similar impact of estrogen combined with progestin and estro­gen alone. In a follow-up study in Uppsala, Sweden, the relative risk of MI was 0.64 (95% CI, 0.45-0.90) for women taking estrogen with progestin. In the Nurses’ Health Study, the relation of hormone use to CHD was similar for users of estrogen alone (RR = 0.56; 95% CI, 0.46-0.68) and estrogen com­bined with progestin (RR = 0.66; 95% CI, 0.49-0.87), after adjusting for an array of coronary risk factors.

Although limited data are available regarding hormone therapy and secondary prevention of CHD, the only published, large-scale randomized clinical trial on hormones and CVD included only women with established CHD. The Heart and Estrogen/progestin Replacement Study (HERS) (10) randomized 2763 women with coronary disease to 0.625 mg of oral conjugated estrogen combined with 2.5 mg of continuous medroxyprogesterone acetate (n = 1380) or placebo (n = 1383). Surprisingly, there was no overall protection against second coronary events for women assigned to treatment, compared to those given placebo (RR = 0.99; 95% CI, 0.80-1.22). However, as also suggested by the preliminary results released from the Women’s Health Initiative, there was a strong trend of decreas­ing risk of heart disease with increasing duration of hormone use (p-trend = 0.009). In the first year of the trial, the risk of major coronary disease increased 52% among treated women; in the second year, there was no relation between treatment and disease (RR = 1.00), and in the third year the relative risk was 0.87.

Recent data from the Nurses’ Health Study report similar results to the HERS trial. Among 2489 postmenopausal participants with previous coronary disease, we identified 213 cases of recurrent nonfatal myocardial infarctions or coronary deaths. We also observed a trend of decreasing risk of recurrent events with increasing time since initiation of current hormone use (p-trend = 0.002). For users of less than 1 year, the multivariate-adjusted relative risk of major CHD was 1.25 (95% CI, 0.78-2.00), compared to never users. After 2 or more years since beginning hormone use, we found a significantly lower rate of CHD events in current hormone users than in never users (RR = 0.38; 95% CI, 0.22-0.66). Overall, with up to 20 years of follow-up, the relative risk of a second event for current hormone users was 0.65 (95% CI, 0.45-0.95); one can only speculate whether the HERS results may also have indicated overall protection had the follow-up been extended for a longer period of time.

Our use of the term or terms Safyral Side Effect is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Safyral Side Effect News visit our site often.

Safyral Side Effect

Pradaxa Lawsuit News – 2/14/2012: If you were prescribed Pradaxa and have suffered negative side effects, please contact us today so that we can put you in touch with an attorney to advise you of your legal rights.

Pradaxa Lawsuit: There are over 795,000 new and recurrent strokes each year. Someone in the United States has a stroke every 40 seconds. Stroke is the third leading cause of death in America today— and a leading cause of long-term adult disability. Approximately 160,000 people die from stroke every year— and 5.5 million survivors continue to suffer its aftermath. One out of every ten families is touched by stroke.

The American Stroke Association’s definition says it all: “A stroke occurs when blood flow to the brain is interrupted by a blocked or burst blood vessel.” Period. But this sudden disruption can be years in the making. It can be the result of clogged blood vessels in the brain, the buildup over time of the fatty cholesterol deposits that translate into atherosclerosis. This disruption also can be created from a blood clot that travels to the brain from another part of the body, a clot that can become lodged in the blood vessels and, acting like a dam, stop”ping the blood supply from getting through to hungry cells.

Or, less commonly, a stroke can be caused by a weakness in blood vessel walls. This vulnerability, present from birth or from uncontrolled high blood pressure, eventually can cause a blowout in the vessel. The blood then will hemorrhage, or leak out, into the brain. But whatever the disruption, the result is the same: the area beyond the clogged blood vessel, beyond the clot, beyond the hem”orrhaging blowout, is not getting the blood supply that it needs. Like a lawn that isn’t watered in a drought, this area of the brain begins to dry up, to shrivel. The brain cells that aren’t “watered” will die very quickly.

TIA is a name to remember. It stands for transient ischemic at”tack and it can save your life. Sudden blurred vision, numbness or weakness, or difficulty in speaking that lasts only a few min”utes or less than twenty-four hours can be a sign that things are amiss—and that it’s time to take immediate care of yourself. In fact, if you experience these transient symptoms, you should call 911, immediately go to the emergency room, and hopefully pre”vent a stroke.

Whoever coined “There’s more here than meets the eye” could very well have been a neurologist. Frankly, it’s not much to look at. A brain looks like a well-used sponge. But appearances lie. The brain is bursting with energy. It consists of billions of nerve cells called neurons. And these neu”rons are settled in specific locales that are responsible for every”thing from the way we eat to the food we like. And this so-called “sponge” can soak up so much information that nothing, not even the most sophisticated computer in the world, can compare to it. Nothing. As with most things, organization, delegation, and record keeping are crucial factors in its success. Despite its lumpy ap”pearance, the brain is very active and very well organized—and in touch with all its “employees.”

Pradaxa Lawsuit: Additional Information and Resources

Pradaxa Lawsuit: Veins, arteries, and nerves—all are intertwined, all are intricately spread throughout our bodies. When we touch a hot plate with our fingers, when we step on a nail, when we bang into the corner of a table, when we sip an ice-cold glass of champagne, when”ever our senses are involved, so is our peripheral nervous system, sending our sensations, or stimuli, to our brain for responses. In normal brain functioning, the brain sends messages back down to those nerve endings, telling us to move our fingers from the hot plate or feel the pain of the nail, the table corner, the ice-cold ache of sipping a drink. The peripheral nervous system is like a vast messenger service, the adjunct staff so important to any suc”cessful organization.

The brain feeds on oxygen, which is extracted from red blood cells. It’s assured a constant supply from the high-speed pumping action of the heart, which, despite the soul-searching words of poets and philosophers, is actually a “hard-body” muscle that is about the size of a fist. This “fist,” however, can squirt a jet of life-sustaining blood several feet. You can feel this jet of blood surging through your body by taking your pulse. Each beat of your pulse pushes out about one cup of blood into your bloodstream. But quality is more important than quantity. Believe it or not, our bodies contain only about twelve pints—or twenty-four cups—of blood. This is equivalent to approximately six quarts of milk or the weight of one Thanksgiving turkey.

The twelve pints of blood pumped by the heart are, in effect, used over and over again. They go around and around in an endless circle throughout our bodies, delivering the blood’s oxygen to all our organs and taking away their wastes. This process is called circulation. Briefly, here’s how it works: The heart is divided into four chambers, the. right and left atrium and the right and left ventricle. The oxygen-filled blood from the lungs comes into the left atrium of the heart. It moves into the left ventricle and is pumped out into the bloodstream through the aorta, the “king” of all arteries. From the aorta, blood, carrying our body’s fuel and food, travels through its passageways called arteries. The walls of the arteries are very elastic; they are muscular tubes that branch out, becom”ing smaller and smaller, until they are only one cell thick.

Fuel and oxygen can pass through them. These tiny arteries are called capillaries. The hungry cells in the body, from the muscles to the brain, from the kidneys to the liver, “eat” their fill and deposit carbon dioxide through their cell walls. The depleted, waste-carrying blood now begins its journey home through the veins. The blood is now more sluggish. The heart has used most of its energy to pump oxygen-rich blood into the body; it has less “oomph” for the return trip. Thus, the veins have little “pockets” or valves that catch any “back”flow” to make sure the blood keeps moving toward the heart and doesn’t get backed up. The veins get bigger and bigger until they reach the right atrium of the heart. As the heart pumps and clenches, this blood is pushed into the right ventricle, where it travels to the lungs and fills up once again with oxygen. This oxygen-rich blood journeys back to the left side of the heart, and the cycle begins anew.

Pradaxa Lawsuit: News and Information from related Sources

Pradaxa Lawsuit: Like the water in your house, circulation needs pressure to keep moving. Your blood pressure is what keeps your blood flowing and moving in a rhythmic way through your arteries. When you get your blood pressure taken, the upper num”ber in the reading, called the systolic pressure, reflects how hard your heart has to squeeze and contract to push the blood through your arteries. A high reading means that your heart is having to squeeze too hard to keep your blood moving. The lower number, or the diastolic pressure, reflects the pressure in your arteries while the heart rests between beats. A high number here means that the pressure remains elevated even when your heart is resting between beats.

Blood flow, its rhythm and pressure, can be affectedby hered”itary factors, kidney disease, weight gain, and cholesterol, a waxy substance that is carried through the bloodstream. As it builds up, cholesterol is deposited on the arterial walls. Eventually, the walls of the arteries thicken to the point where blood may not get through. If these deposits occur in the arteries feeding the heart, this can result in a heart attack. If they accumulate in the arteries feeding the brain, this can result in a stroke.

The brain has a hungry man’s appetite. It needs 20 percent of the total blood supply to get the oxygen and food that it needs. The crucial arteries through which the heart pumps blood up to the hungry brain are called the carotid arteries. Both the right and the left carotid arteries are all-important, branching out into a series of arteries in the front of the neck and into the brain. These arteries grow smaller and smaller as they travel, allowing all the areas of the brain, from the thalamus to the hippocam”pus, from the frontal to the temporal lobes, to get “served” with oxygen-rich blood.

Pradaxa Lawsuit: Information and News

Pradaxa Lawsuit: Blood. We can be upset by the sight of it or donate it to save a life. But whatever the “gut feeling,” blood is literally a carrier—of life. Think of it as a highly reputable moving van, a transporter that carries necessary food to our cells. And there is much more than meets the eye in its red color. If you put a drop of blood under a microscope, you’d see all of the following: Plasma is the liquid that holds the blood cells; it gives the blood its consistency. The red blood cells (or corpuscles) hold the food. They contain the oxygen and the other nutrients (in the chemical form of glucose) that the body needs to survive. After the various organs finish their “meal,” these red blood cells head for the veins, carrying back the “empty plates” to the heart. Red blood cells also give the blood its red color.

The white blood cells are the “superheroes.” They respond to “foreign invaders/’ both by fighting infection and by increasing in number when infection or inflammation threatens the body. The platelets are responsible for clotting. When you cut yourself, platelets “rush in” and begin to create a web, a microscopic gauze of fiber, that traps other blood cells to stop the flow of blood. Problems can arise, however, in the most well-oiled ma”chine—and the human body is no exception. Clotting is crucial if you fall and hurt your knee, if you step on that ever-present nail. However, especially as we get older, our arteries can narrow and develop rough areas, which draw the attention of the platelets.

Our use of the term or terms Pradaxa Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Pradaxa Lawsuit visit our site often.

Pradaxa Lawsuit

Both plaintiffs and defendants in asbestos lawsuits agree that asbestoscauses 80 to 90 percent of all mesothelioma cases. You would think that it naturally follows that 80 to 90 percent of mesothelioma lawsuit plaintiffs do not have to prove to a jury that asbestos exposure caused their mesothelioma. Until recently, that was not the case. Instead, through a legal process called reverse bifurcation, most if not all mesothelioma lawsuit plaintiffs had to first prove in court that their mesothelioma diagnosis is tied to past asbestos exposure. Once this was proved – and it usually was — most cases settled out of court.

Now, as reported by the Legal Intelligencer, after nearly a quarter of a century of trying asbestos lawsuits with reverse bifurcation, the Philadelphia Common Pleas Court’s mass torts program for asbestos began “straight-through trials” of asbestos cases in which it is uncontested that plaintiffs have mesothelioma because of asbestos exposure.

“Straight through trial” basically means that the plaintiffs do not first have to prove to the court – with documents and records and other evidence – that asbestos exposure caused their mesothelioma. Instead, the court takes for granted that it did, in which case most lawsuits settle out of court. So far though, even those that have gone through to trial have ended favorably for plaintiffs. One such mesothelioma patient and his family won $4.5 million in a recent trial verdict.

It’s good news for mesothelioma victims and not so good news for some defendants who make or have made asbestos-containing products. Examples of companies that had ready defenses to disprove asbestos exposure from their products as the cause of mesothelioma in a plaintiff include break pad manufacturers and insulation companies. These defendants would use reverse bifurcation to fight off taking responsibility for the victim’s illness. Hopefully, more states will follow PA’s lead on this.

If you or a loved one has suffered from asbestos exposure and later developed mesothelioma, call an asbestos attorney at Sokolove Law today for a free consultation.

Asbestos

A new study financed by a section of the National Institutes of Health has made the first potential connection to an individual’s genetics and susceptibility to eventually developing deadly asbestos illnesses such as mesothelioma.

The study, which was recently published online in Nature Genetics, found evidence that people with BAP1 gene mutations may have an increased chance of developing multiple cancer types such as mesothelioma, breast, ovarian, pancreatic and renal cancers. The study highlighted two U.S. families with members who have the BAP1 gene mutation. Both families also have “a high incidence of mesothelioma.”

Dr. Joseph R. Testa, another study co-leader and the Carol and Kenneth E. Weg chairman in Human Genetics at Fox Chase Cancer Center, said the study was the first to “demonstrate that individual genetic makeup can greatly influence susceptibility to mesothelioma.”

While only a first step, the discoveries noted in this study could one day lead to fundamental progress in mesothelioma care. Thanks to Drs. Carbone and Testa and their crew for the hard work. We hope this is just the beginning of bigger breakthroughs to come.

Living with the day-to-day hardships of mesothelioma – whether it is you or a loved one who has been diagnosed with the illness – is both emotionally and financially taxing. If you feel that a company or former employer may be responsible for the asbestos exposure that led to an illness, contact a mesothelioma attorney to learn about filing amesothelioma lawsuit.

Mesothelioma

Medical liability cases against obstetricians and other doctors who participate in the birthing process are most often spurred by errors in clinical judgment, miscommunication between doctors, and technical mistakes.

All of these errors can potentially result in a birth injury occurring that may remain with the newborn child for their entire lives.

According to a study released this month by CRIGO Strategies that analyzed more than 800 OB medical liability cases filed between 2005 and 2009, the three most common allegations in the lawsuits were as follows: Delayed treatment of fetal distress, improper execution of vaginal delivery, and improper management of pregnancy.

“Obstetrics has some unique vulnerabilities, most often involving situations in which a sequence of errors or oversights cascade into a crisis that can put mother and baby in jeopardy,” said Robert Hanscom, CRIGO’s senior vice president.

Obstetrician errors can result in a number of birth injuries that can affect the mother and/or the child being born. Among the more serious birth injuries a newborn can suffer from is cerebral palsy, which can affect a newborn for the rest of his or her life and often relegate them to a wheelchair and constant medical care.

If you or your child was born with a birth injury that can be attributed to medical error, such as cerebral palsy, there may be legal options available to you. Contact a birth injury attorney at Sokolove Law today to learn about your options regarding a lawsuit against the doctors who caused your injury.

Birth Injury

Aside from legal ads on TV, many Americans don’t know what asbestos is or where it can be found, let alone that exposure to this dangerous material can result in the development of an asbestos-related cancer such as mesothelioma. In fact, mesothelioma occurs in such a small number of patients – it’s estimated that only 2,500-3,000 new patients are diagnosed every year – that the disease is often referred to as an orphan disease. And while new mesothelioma treatments can alleviate symptoms and improve a patient’s quality of life, to date there is no proven cure for the disease.

Perhaps most troubling is the fact that despite these known health risks, asbestos is still not banned in the United States and is manufactured and used every day.

But you can help change this. There are a number of easy ways for you to join the fight to ban asbestos and beat mesothelioma forever, and it all begins with one simple goal: raising awareness.

Each year, the Mesothelioma Applied Research Foundation (MARF) recognizes September 26 as National Mesothelioma Awareness Day in order to educate the public about the dangers of asbestos exposure and raise much-needed financial support for research towards improved treatments of the disease. The first Mesothelioma Awareness Day was started in 2004 by a group of volunteers and every year since has been larger and more widespread.

Want to participate, but don’t know where to start? Here are some ideas:

• Write a letter to Congress urging them to ban asbestos. We have a pre-written letter on our homepage you can sign and send digitally in minutes. (Yes, your representatives really receive them and sometimes they’ll even write you back!)
• Spread the word! You can click the Facebook and Twitter buttons on the top or bottom of this page to easily share the news about Mesothelioma Awareness Day with your friends.
• Join MARF’s social media campaign. They have ready-to-use facts and updates for you to share online.
• Plan or attend a fundraising event. You can check MARF’s event calendar to see if there’s anything planned in your area, and if there isn’t, they have otherideas how you can become involved – both on 9/26, as well as throughout the year.
• Make a donation to a non-profit organization like MARF or the Asbestos Disease Organization (ADAO).
• Check out the Mesothelioma Resource Center’s list of ways to raisemesothelioma awareness, which include contacting local news outlets, meeting local government leaders, fundraising and more.

Whether it’s the click of a mouse or a dollar in a donation jar, you CAN make a difference on National Mesothelioma Awareness Day. By raising awareness, we can save lives through safety education and prevention, as well as gaining support for the movements to ban asbestos and secure additional funding for improved treatments.

So take action and spread the word! Together, we can ban asbestos and beat asbestos-related diseases like mesothelioma.

Mesothelioma

Both plaintiffs and defendants in asbestos lawsuits agree that asbestoscauses 80 to 90 percent of all mesothelioma cases. You would think that it naturally follows that 80 to 90 percent of mesothelioma lawsuit plaintiffs do not have to prove to a jury that asbestos exposure caused their mesothelioma. Until recently, that was not the case. Instead, through a legal process called reverse bifurcation, most if not all mesothelioma lawsuit plaintiffs had to first prove in court that their mesothelioma diagnosis is tied to past asbestos exposure. Once this was proved – and it usually was — most cases settled out of court.

Now, as reported by the Legal Intelligencer, after nearly a quarter of a century of trying asbestos lawsuits with reverse bifurcation, the Philadelphia Common Pleas Court’s mass torts program for asbestos began “straight-through trials” of asbestos cases in which it is uncontested that plaintiffs have mesothelioma because of asbestos exposure.

“Straight through trial” basically means that the plaintiffs do not first have to prove to the court – with documents and records and other evidence – that asbestos exposure caused their mesothelioma. Instead, the court takes for granted that it did, in which case most lawsuits settle out of court. So far though, even those that have gone through to trial have ended favorably for plaintiffs. One such mesothelioma patient and his family won $4.5 million in a recent trial verdict.

It’s good news for mesothelioma victims and not so good news for some defendants who make or have made asbestos-containing products. Examples of companies that had ready defenses to disprove asbestos exposure from their products as the cause of mesothelioma in a plaintiff include break pad manufacturers and insulation companies. These defendants would use reverse bifurcation to fight off taking responsibility for the victim’s illness. Hopefully, more states will follow PA’s lead on this.

If you or a loved one has suffered from asbestos exposure and later developed mesothelioma, call an asbestos attorney at Sokolove Law today for a free consultation.

Asbestos